Stojkovska, Iva
Krainc, Dimitri
Mazzulli, Joseph R.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS076054, R01NS092823)
Article History
Received: 5 June 2017
Accepted: 16 September 2017
First Online: 24 October 2017
Compliance with ethical standards
:
: JRM and DK are co-founders of Lysosomal Therapeutics, Inc., a company that uses lysosomal biology to develop treatments for neurodegenerative disease.